June 16 (Bloomberg) -- Medtronic Inc., the second-largest maker of medical devices, agreed to buy Covidien Plc for $42.9 billion in cash and stock as it transforms into a broader-based company bolstered by new tax advantages.
This Announcement is Being Made Solely to Comply with the Requirements of the Irish Takeover Rules. the Information Set out Herein Concerning the Results of Covidien plc's Shareholder Meetings on January 6, 2015 Will Also Be Set out in Covidien plc's ...
Standard & Poor's Ratings Services today said its ratings on Covidien plc (NYSE: COV), including its 'A' corporate credit rating and issue-level ratings, remain on CreditWatch with positive implications.
Covidien plc (NYSE:COV) is one of new positions the fund disclosed in its latest 13F. According to the filling, Rail-Splitter Capital Management holds 121,970 shares of the company, valued at $12.48 million.
Covidien plc (NYSE: COV) announced that the U.S. District Court for the District of Connecticut has granted a preliminary injunction against Ethicon Endo-Surgery, Inc., a Johnson & Johnson (NYSE: JNJ) company.